| Filed On | Filing |
|---|---|
| 10 Nov 2026 | SCHEDULE 13G |
| 05 Nov 2026 |
Form 4: Breber Pierre R, Director
Bought 4,000 shares ($400K) |
| 02 Nov 2026 | 10-Q |
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
OAKLAND, Calif., Nov. 2, 2026 — The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2027, which ended Sept. 30, 2026. |
| 29 Oct 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 29 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
OAKLAND, Calif., Oct. 29, 2026 — The Clorox Company (NYSE: CLX) today announced that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan. 5, 2027, following a comprehensive search. Garcia will succeed Linda Rendle, w... |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 07 Oct 2026 |
Form 4: Rendle Linda J, Director
Received 29,352 shares as a grant or award ($2.36M) · Gave up 12,681 shares to cover exercise price or tax ($1.02M) |
| 07 Oct 2026 |
Form 4: Peck Laurene E, VP - CAO & Corp Controller
Received 1,172 shares as a grant or award ($94.2K) · Gave up 369 shares to cover exercise price or tax ($29.7K) |
| 07 Oct 2026 |
Form 4: Marriner Kirsten, EVP - Chief Admin Officer
Received 6,637 shares as a grant or award ($534K) · Gave up 4,093 shares to cover exercise price or tax ($329K) |
| 07 Oct 2026 |
Form 4: Hyder Chris T, EVP-Chief Operating Officer
Received 4,191 shares as a grant or award ($337K) · Gave up 1,632 shares to cover exercise price or tax ($131K) |
| 07 Oct 2026 |
Form 4: Hilt Angela C, EVP - Chief Legal Officer
Received 6,637 shares as a grant or award ($534K) · Gave up 4,647 shares to cover exercise price or tax ($374K) |
| 07 Oct 2026 |
Form 4: Bellet Luc, EVP - Chief Financial Officer
Received 1,677 shares as a grant or award ($135K) · Gave up 1,611 shares to cover exercise price or tax ($130K) |
| 07 Oct 2026 |
Form 4: Barton Nina, EVP-Chief Growth & Strategy Of
Gave up 1,106 shares to cover exercise price or tax ($88.9K) |
| 07 Oct 2026 | ARS |
| 07 Oct 2026 | DEFA14A |
| 07 Oct 2026 |
Proxy statement: annual meeting on November 18, 2026
CEO pay $14.0M, up 5% · say-on-pay vote |
| 02 Oct 2026 |
Form 4: Williams Christopher J, Director
Granted 276.2573 Deferred Stock Units · Granted 339.4642 Deferred Stock Units |
| 02 Oct 2026 |
Form 4: Weiner Russell J, Director
Granted 226.7613 Deferred Stock Units · Granted 416.6152 Deferred Stock Units |
| 02 Oct 2026 |
Form 4: Shattock Matthew J, Director
Granted 255.3782 Deferred Stock Units · Granted 648.0681 Deferred Stock Units |
Loading...